Cargando…

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)

BACKGROUND: Irritable Bowel Syndrome (IBS) is a common gastro-intestinal disorder in primary and secondary care, characterised by abdominal pain, discomfort, altered bowel habits and/or symptoms of bloating and distension. In general the efficacy of drug therapies is poor. Hypnotherapy as well as Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Flik, Carla E, van Rood, Yanda R, Laan, Wijnand, Smout, André JPM, Weusten, Bas LAM, Whorwell, Peter J, de Wit, Niek J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285532/
https://www.ncbi.nlm.nih.gov/pubmed/22185606
http://dx.doi.org/10.1186/1471-230X-11-137
_version_ 1782224481847083008
author Flik, Carla E
van Rood, Yanda R
Laan, Wijnand
Smout, André JPM
Weusten, Bas LAM
Whorwell, Peter J
de Wit, Niek J
author_facet Flik, Carla E
van Rood, Yanda R
Laan, Wijnand
Smout, André JPM
Weusten, Bas LAM
Whorwell, Peter J
de Wit, Niek J
author_sort Flik, Carla E
collection PubMed
description BACKGROUND: Irritable Bowel Syndrome (IBS) is a common gastro-intestinal disorder in primary and secondary care, characterised by abdominal pain, discomfort, altered bowel habits and/or symptoms of bloating and distension. In general the efficacy of drug therapies is poor. Hypnotherapy as well as Cognitive Behaviour Therapy and short Psychodynamic Therapy appear to be useful options for patients with refractory IBS in secondary care and are cost-effective, but the evidence is still limited. The IMAGINE-study is therefore designed to assess the overall benefit of hypnotherapy in IBS as well as comparing the efficacy of individual versus group hypnotherapy in treating this condition. METHODS/DESIGN: The design is a randomised placebo-controlled trial. The study group consists of 354 primary care and secondary care patients (aged 18-65) with IBS (Rome-III criteria). Patients will be randomly allocated to either 6 sessions of individual hypnotherapy, 6 sessions of group hypnotherapy or 6 sessions of educational supportive therapy in a group (placebo), with a follow up of 9 months post treatment for all patients. Ten hospitals and four primary care psychological practices in different parts of The Netherlands will collaborate in this study. The primary efficacy parameter is the responder rate for adequate relief of IBS symptoms. Secondary efficacy parameters are changes in the IBS symptom severity, quality of life, cognitions, psychological complaints, self-efficacy as well as direct and indirect costs of the condition. Hypnotherapy is expected to be more effective than the control therapy, and group hypnotherapy is expected not to be inferior to individual hypnotherapy. DISCUSSION: If hypnotherapy is effective and if there is no difference in efficacy between individual and group hypnotherapy, this group form of treatment could be offered to more IBS patients, at lower costs. TRIAL REGISTRATION NUMBER: ISRCTN: ISRCTN22888906
format Online
Article
Text
id pubmed-3285532
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32855322012-02-24 A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study) Flik, Carla E van Rood, Yanda R Laan, Wijnand Smout, André JPM Weusten, Bas LAM Whorwell, Peter J de Wit, Niek J BMC Gastroenterol Study Protocol BACKGROUND: Irritable Bowel Syndrome (IBS) is a common gastro-intestinal disorder in primary and secondary care, characterised by abdominal pain, discomfort, altered bowel habits and/or symptoms of bloating and distension. In general the efficacy of drug therapies is poor. Hypnotherapy as well as Cognitive Behaviour Therapy and short Psychodynamic Therapy appear to be useful options for patients with refractory IBS in secondary care and are cost-effective, but the evidence is still limited. The IMAGINE-study is therefore designed to assess the overall benefit of hypnotherapy in IBS as well as comparing the efficacy of individual versus group hypnotherapy in treating this condition. METHODS/DESIGN: The design is a randomised placebo-controlled trial. The study group consists of 354 primary care and secondary care patients (aged 18-65) with IBS (Rome-III criteria). Patients will be randomly allocated to either 6 sessions of individual hypnotherapy, 6 sessions of group hypnotherapy or 6 sessions of educational supportive therapy in a group (placebo), with a follow up of 9 months post treatment for all patients. Ten hospitals and four primary care psychological practices in different parts of The Netherlands will collaborate in this study. The primary efficacy parameter is the responder rate for adequate relief of IBS symptoms. Secondary efficacy parameters are changes in the IBS symptom severity, quality of life, cognitions, psychological complaints, self-efficacy as well as direct and indirect costs of the condition. Hypnotherapy is expected to be more effective than the control therapy, and group hypnotherapy is expected not to be inferior to individual hypnotherapy. DISCUSSION: If hypnotherapy is effective and if there is no difference in efficacy between individual and group hypnotherapy, this group form of treatment could be offered to more IBS patients, at lower costs. TRIAL REGISTRATION NUMBER: ISRCTN: ISRCTN22888906 BioMed Central 2011-12-20 /pmc/articles/PMC3285532/ /pubmed/22185606 http://dx.doi.org/10.1186/1471-230X-11-137 Text en Copyright ©2011 Flik et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Flik, Carla E
van Rood, Yanda R
Laan, Wijnand
Smout, André JPM
Weusten, Bas LAM
Whorwell, Peter J
de Wit, Niek J
A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title_full A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title_fullStr A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title_full_unstemmed A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title_short A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
title_sort randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the imagine study)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285532/
https://www.ncbi.nlm.nih.gov/pubmed/22185606
http://dx.doi.org/10.1186/1471-230X-11-137
work_keys_str_mv AT flikcarlae arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT vanroodyandar arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT laanwijnand arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT smoutandrejpm arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT weustenbaslam arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT whorwellpeterj arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT dewitniekj arandomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT flikcarlae randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT vanroodyandar randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT laanwijnand randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT smoutandrejpm randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT weustenbaslam randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT whorwellpeterj randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy
AT dewitniekj randomisedcontrolledtrialonhypnotherapyforirritablebowelsyndromedesignandmethodologicalchallengestheimaginestudy